Several other investigations have showed that simvastatin induces apoptosis in breast cancer, chronic myeloid leukemia (CML) and lung cancer cells via changing the balance between pro- and anti-apoptotic Bcl2 family proteins [69]. This evidence concerns the gene BCL2 and lung carcinoma.